APA (7th ed.) Citation

Mohammad Z. Ahmed, Qamar Zia, Anzarul Haque, Ali S. Alqahtani, Omar M. Almarfadi, Saeed Banawas, . . . Shafiul Haque. (2021). Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: An in silico drug repurposing study on FDA-approved antiviral and anti-infection agents. Elsevier.

Chicago Style (17th ed.) Citation

Mohammad Z. Ahmed, Qamar Zia, Anzarul Haque, Ali S. Alqahtani, Omar M. Almarfadi, Saeed Banawas, Mohammed S. Alqahtani, Keshav L. Ameta, and Shafiul Haque. Aminoglycosides as Potential Inhibitors of SARS-CoV-2 Main Protease: An in Silico Drug Repurposing Study on FDA-approved Antiviral and Anti-infection Agents. Elsevier, 2021.

MLA (9th ed.) Citation

Mohammad Z. Ahmed, et al. Aminoglycosides as Potential Inhibitors of SARS-CoV-2 Main Protease: An in Silico Drug Repurposing Study on FDA-approved Antiviral and Anti-infection Agents. Elsevier, 2021.